DSCO Key Stats
- SmithOnStocks Opines On Stocks: May 19th Edition May 19
- 7 Biotechnology Stocks to Sell Now Investor Place May 15
- Discovery Labs Announces Completion of $14.25 Million Public Offering PR Newswire May 15
- Discovery Labs to Float Stock Issue May 10
- Discovery Labs (DSCO) Prices 9.5M Common Stock Offering Street Insider May 10
- Discovery Labs Prices $14.25 Million Public Offering of Common Stock PR Newswire May 10
- DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Entry into a Material Defini... May 10
- Discovery Labs files to sell common stock, no amount given May 9
- Discovery Labs (DSCO) Announces Common Stock Offering Street Insider May 9
- Discovery Labs Announces Proposed Public Offering of Common Stock PR Newswire May 9
DSCO Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Discovery Laboratories is down 36.72% over the last year vs S&P 500 Total Return up 28.68%, Acorda Therapeutics up 45.58%, and Achillion Pharmaceuticals up 7.49%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Pro Ratings for DSCO
Pro Report PDF for DSCO
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download DSCO Pro Report PDF
Pro Strategies Featuring DSCO
Did Discovery Laboratories make it into our Pro Portfolio Strategies?